IL-1 and EGF regulate expression of genes important in inflammation and cancer

被引:60
作者
Kasza, Aneta [1 ]
机构
[1] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Cell Biochem, PL-30387 Krakow, Poland
关键词
Inflammation; Inflammasomes; EGF; IL-1; receptor; NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; NECROSIS-FACTOR-ALPHA; MIGRATION INHIBITORY FACTOR; TOLL-LIKE RECEPTORS; DEPENDENT KINASE INHIBITOR; C-TYPE LECTINS; RETINOBLASTOMA PROTEIN; TARGETED THERAPY; INNATE IMMUNITY;
D O I
10.1016/j.cyto.2013.02.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This review focuses on the mechanisms by which the expression of specific genes is regulated by two proteins that are important in inflammation and cancer, namely the pro-inflammatory cytokine interleukin (IL)-1 beta and epidermal growth factor (EGF). In the review the receptors that recognize factors that cause inflammation are described with main focus on the receptors associated with activation of IL-1 beta. The function of IL-1 beta and pathways leading to activation of transcription factors, particularly NF kappa B and Elk-1 are analyzed. Then the mechanisms of EGF action, with particular emphasis of the activation of Elk-1 are illustrated. The link between aberrant signaling of EGF receptor family members and cancer development is explained. The relationship between inflammation and tumorigenesis is discussed. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:22 / 33
页数:12
相关论文
共 161 条
  • [1] Inflammation and cancer: How hot is the link?
    Aggarwal, Bharat B.
    Shishodia, Shishir
    Sandur, Santosh K.
    Pandey, Manoj K.
    Sethi, Gautam
    [J]. BIOCHEMICAL PHARMACOLOGY, 2006, 72 (11) : 1605 - 1621
  • [2] Innate immunity and adjuvants
    Akira, Shizuo
    [J]. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2011, 366 (1579) : 2748 - 2755
  • [3] TRANSFORMING P21(RAS) MUTANTS AND C-ETS-2 ACTIVATE THE CYCLIN D1 PROMOTER THROUGH DISTINGUISHABLE REGIONS
    ALBANESE, C
    JOHNSON, J
    WATANABE, G
    EKLUND, N
    VU, D
    ARNOLD, A
    PESTELL, RG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) : 23589 - 23597
  • [4] The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions
    Apte, Ron N.
    Dotan, Shahar
    Elkabets, Moshe
    White, Malka R.
    Reich, Eli
    Carmi, Yaron
    Song, Xiaping
    Dvozkin, Tatyana
    Krelin, Yakov
    Voronov, Elena
    [J]. CANCER AND METASTASIS REVIEWS, 2006, 25 (03) : 387 - 408
  • [5] Arlt A, 2002, CANCER RES, V62, P910
  • [6] The E2F family: specific functions and overlapping interests
    Attwooll, C
    Denchi, EL
    Helin, K
    [J]. EMBO JOURNAL, 2004, 23 (24) : 4709 - 4716
  • [7] EGFR gene amplification in breast cancer:: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
    Bhargava, R
    Gerald, WL
    Li, AR
    Pan, QL
    Lal, P
    Ladanyi, M
    Chen, BY
    [J]. MODERN PATHOLOGY, 2005, 18 (08) : 1027 - 1033
  • [8] Tumor Growth-Promoting Properties of Macrophage Migration Inhibitory Factor
    Bifulco, Carlo
    McDaniel, Katy
    Leng, Lin
    Bucala, Richard
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (36) : 3790 - 3801
  • [9] A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells
    Black, RA
    Rauch, CT
    Kozlosky, CJ
    Peschon, JJ
    Slack, JL
    Wolfson, MF
    Castner, BJ
    Stocking, KL
    Reddy, P
    Srinivasan, S
    Nelson, N
    Boiani, N
    Schooley, KA
    Gerhart, M
    Davis, R
    Fitzner, JN
    Johnson, RS
    Paxton, RJ
    March, CJ
    Cerretti, DP
    [J]. NATURE, 1997, 385 (6618) : 729 - 733
  • [10] Adams: Key components in EGFR signalling and development
    Blobel, CP
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2005, 6 (01) : 32 - 43